Yongen Chang
Assistant Clinical Professor, Medicine
School of Medicine
School of Medicine
Fellowship Program Director, Nephrology
M.D., Fudan University Medical Center, 2001
Ph.D., Cornell University, 2007
Ph.D., Cornell University, 2007
Phone: (Office) 714-456-5142; (Clinic) 714-456-7720; (Fellowship) 714-456-5413
Fax: 714-456-6034
Email: cyongen@uci.edu
Fax: 714-456-6034
Email: cyongen@uci.edu
University of California, Irvine
333 City Blvd West
Suite 400
Mail Code: 4088
Orange, CA 92868
333 City Blvd West
Suite 400
Mail Code: 4088
Orange, CA 92868
Research Interests
Chronic Kidney Disease, Renal Fibrosis, Tissue injury and repair, Integrin biology
Research Abstract
Dr. Chang completed her fellowship in Nephrology at the University of California, San Francisco. Her clinical interests include refractory/resistant hypertension, chronic kidney disease, kidney diseases in pregnancy and malignancy and rare glomerulonephritis. Dr. Chang has also conducted translational research focusing on the molecular mechanisms of renal fibrosis and chronic kidney disease in animal models. She was awarded the Ben J. Lipps Research Fellowship from the American Society of Nephrology and the Ruth L. Kirschstein National Research Service Award (F32 NRSA) from the National Institutes of Health. Dr. Chang has presented her work at various international meetings and has published in several high-impact, peer-reviewed journals.
Dr. Chang is board certified in Internal Medicine and Nephrology, and an active member of the American Society of Nephrology. She is also fluent in Mandarin Chinese.
Dr. Chang is board certified in Internal Medicine and Nephrology, and an active member of the American Society of Nephrology. She is also fluent in Mandarin Chinese.
Publications
Hingdi S.M., Wang Y., Jones K.D., Nussbaum J.C., Chang Y., Masharani U., Bikle D., Shoback D.M., Hsiao E.C., A case of hypercalcemia and overexpression of CYP27B1 in skeletal muscle lesions in a patient with HIV infection after cosmetic injections with polymethylmethacrylate (PMMA) for wasting. Calcif Tissue Int, 2015
Chang Y., Mbeo G., Littman S.J., Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma. J. Gastrointest. Cancer, 2011
Nandrot E.F., Chang Y., Finnemann S.C., avß5 integrin receptors at the apical surface of the RPE: one receptor, two functions. Adv. Exp. Med. Biol., 2008
Chang Y., Finnemann S.C., Photoreceptor-RPE interactions: physiology and molecular mechanisms. Visual Transduction and Non-Visual Light Perception, Vol. 4. 2008, The Humana Press Inc.
Chang Y., Finnemann S.C., Tetraspanin CD81 is required for the avß5 integrin-dependent particle binding step of RPE phagocytosis. Journal of Cell Science, 2007
Chang Y., Jiang Y., The definition of glomerulonephritis. Nephritis and Urinary Infection. Shanghai Science & Technology Publishing Co., Ltd. 1999
Chang Y., Mbeo G., Littman S.J., Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma. J. Gastrointest. Cancer, 2011
Nandrot E.F., Chang Y., Finnemann S.C., avß5 integrin receptors at the apical surface of the RPE: one receptor, two functions. Adv. Exp. Med. Biol., 2008
Chang Y., Finnemann S.C., Photoreceptor-RPE interactions: physiology and molecular mechanisms. Visual Transduction and Non-Visual Light Perception, Vol. 4. 2008, The Humana Press Inc.
Chang Y., Finnemann S.C., Tetraspanin CD81 is required for the avß5 integrin-dependent particle binding step of RPE phagocytosis. Journal of Cell Science, 2007
Chang Y., Jiang Y., The definition of glomerulonephritis. Nephritis and Urinary Infection. Shanghai Science & Technology Publishing Co., Ltd. 1999
Professional Societies
American Society of Nephrology
Link to this profile
https://faculty.uci.edu/profile/?facultyId=6199
https://faculty.uci.edu/profile/?facultyId=6199
Last updated
01/13/2020
01/13/2020